Pacific Biosciences Of California, Inc. shares fall 1.53% after-hours following Zentek Ltd.'s MD&A release.

Pacific Biosciences Of California, Inc. declined 1.53% in after-hours trading. The recent news event, "Management's Discussion and Analysis For the three-month period ended June 30, 2025," dated August 14, 2025, may have contributed to the stock's decline. The report discusses the financial condition and results of operations of Zentek Ltd., which could have influenced investor sentiment negatively.